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Osteomalacia
Boy Frame, MD"

fd. Note - This overview was originally presented at the
International Symposium on Clinical Disorders of Bone
and Mineral Metabolism, May 9-13, 1983. The following
list indicates the presentations given in this session at the
Symposium and the contents ofthe corresponding
chapter in the Proceedings of the Symposium published by
Excerpta Medica. The numbers in parentheses refer to
pages in this volume. Complete information about the
contents ofthe Proceedings can be found at the back of
this issue.

R e c e n t advances in laboratory methods and techniques
related to bone and mineral metabolism have provided a
detailed study of factors important in bone formation.
Osteomalacia results from a disturbance in mineralization of bone matrix. Theoretically, bone matrix may fail
to mineralize because of abnormalities in collagen and
matrix proteins, or because of an alteration in mineral
metabolism at the mineralization front. The result is an
accumulation of increased quantities of unmineralized
bone matrix (osteoid) over bone surfaces.

Spatial distributions of a l u m i n u m , phosphorus and calcium in mineralizingepiphy seal growth plates of aluminumtreated rats by electron spectroscopic imaging. A.L.
Arsenault, F.P. Ottensmeyer, and A.B. Hodsman (220)

Rickets is more apparent in children who have otherwise
normal growth patterns, including that of the cartilage
present in the growth plates of long bones. Likewise,
osteomalacia is less apt to occur when normal bone
matrix formation is deficient. In order for a defect in
bone mineralization to be fully expressed, adequate
bone matrix must first be deposited.

tfistologic evolution of vitamin-D depletion in patients
with intestinal malabsorption of dietary deficiency. D.S.
Rao, A. Villanueva, M . Matthews, B. Pumo, B. Frame, M .
Kleerekoper, and A . M . Parfitt (224)

The Table lists some of the factors currently considered
to be possibly significant in the formation of bone matrix
and mineralization.

Primary biliary cirrhosis and alcoholic cirrhosis as examples of chronic liver disease associated with bone disease. R.R. Recker, W. Maddrey, H. Herlong, M . Sorrell,
and R. Russell (227)

Recent studies suggest that bone resorption itself may be
important as an initiating event for osteoblast formation
and function in the bone remodeling unit (BMU). A high
molecular weight polypeptide which has been isolated
f r o m tissue cultures and demineralized human bone
matrix, stimulates osteoblast proliferation and matrix
formation. Impaired release or other defect in this coupling or skeletal growth factor could theoretically influence subsequent osteoblast vigor and function.

Chronic hypophosphatemia without osteomalacia. M.C.
de Vernejoul, P.J. Marie, L. Miravet, and A. Ryckewaert
(232)
Bone disease in patients receiving total parenteral n u t r i tion. S.M. Ott, N.A. Maloney, G.L. Klein, A.C. Alfrey,
M.E. Ament, J.W. Coburn, and D.J. Sherrard (237)
The pathogenesis of t u m o r - i n d u c e d osteomalacia: A
new perspective. P.C. Brazy, B. Lobuagh, K.W. Lyles, and
M.K. Drezner (242)

Collagen synthesis is the initial, major component of
bone matrix formation. Maturation of collagen, which
appears to be important for mineralization, is characterized by increasing intra- and extrafibrillar cross-linking
of collagen fibers. Some defects in mineralization may
result from an abnormality in collagen structure. For
instance, in the rare skeletal disorder known as fibro-
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genesis imperfecta ossium, marked distortion of the
normally polarized collagen fibers appears to result in
impaired mineralization and increased numbers of
widened osteoid seams.
The chronologic age of the person as well as the age of
the osteoblasts may influence the rate and extent of
matrix formation. Decreases in the matrix appositional
rate correlates with age and distance from the cement
line in individual BMUs. Only insulin and growth hormone, the latter via somatomedin, directly stimulate
bone collagen synthesis. Other hormones primarily play
a modulating role in collagen formation.
Recently, noncollagenous bone matrix proteins have
been evaluated as possible causes of defective mineralization. Osteocalcin (gla protein) has been extensively
studied, but its ultimate role in bone metabolism is still to
be determined. Osteocalcin has an affinity for binding to
hydroxyapatite but only after the latter's maturation
from an initial amorphous mineral phase. Another bone
matrix protein, osteonectin appears to facilitate the
nucleation of calcium phosphate mineral o n t o the surface of type I collagen.
Proteoglycans and glycoproteins are other important
extracollagenous proteins in bone matrix. While their
role in mineralization needs further clarification, they do
have a high binding affinity for calcium, which apparently depends on the presence of a large number of free
acidic groups. Theoretically, excessive calcium binding
to proteoglycans might interfere with normal mineral
deposition at the mineralization front. In fact, certain
rare forms of osteomalacia may be related to a defect in
concentration or function of one or more of the matrix
proteins. O n e f o r m of osteomalacia that could result
from such a defect is axial osteomalacia. In this skeletal
affliction, osteomalacia of the axial skeleton (exhibiting a
coarsened trabecular pattern on skeletal x-rays) is not
associated with any obvious disturbance in mineral or
vitamin D metabolism. An abnormality in one of the
extracollagenous matrix proteins could account for this
mineralization defect.
Because methods of study are available, most identified
forms of osteomalacia have been related to disturbances
in mineral and vitamin D metabolism. After appropriate
maturation of bone matrix overa period of 10 to 15 days,
primary mineralization occurs, and about 80% of the
mineral is deposited in the first few days. This primary
mineralization is largely controlled by the osteoblasts
and nearby osteoid osteocytes. The remainder of the
mineral is deposited at a slower rate over a six-month
period or more, a process k n o w n as secondary minerali-
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zation. Osteoblast influence is less important in this latter phase of mineral deposition.
A number of precisely timed chemical and physiological
factors must interact for mineralization to proceed normally. Ambient concentrations of calcium and particularly of phosphate are important. Since osteomalacia
occurs in many patients with chronic hypophosphatemia, other modulating factors are also important. In this
section, M.C. de Vernejoul and associates (pp. 232 ff.)
report on 19 male patients with chronic hypophosphatemia due to a renal phosphate leak independent of
parathyroid hormone. Whilethere was noosteoid accumulation, decreased osteoblast appositional rate was nevertheless present. As in rickets, normal growth of bone
matrix may be necessary before a mineralization defect
can be fully expressed.
Relatives of patients with X-linked hypophosphatemic
rickets and osteomalacia may exhibit hypophosphatemia w i t h o u t apparent bone involvement. However,
many of these patients have not had careful bone biopsy
studies with current histomorphometric techniques to
exclude a defect in mineralization. Chronic hypocalcemia appears to result in rickets and osteomalacia only
TABLE
Factors Influencing Bone Matrix
Formation and Mineralization
Bone resorption in bone r e m o d e l i n g units (BRUs)
• Release of a coupling factor that stimulates osteoblasts
Osteoblast f u n c t i o n
• Collagen formation and maturation
1. C h r o n o l o g i c age of person
2. Insulin
3. G r o w t h h o r m o n e (via somatomedin)
• Bone matrix proteins
1. Osteocalcin (Gla protein)
2. Osteonectin
3. Proteoglycans
Mineralization at the mineralization front
• A m b i e n t Ca, PO^ concentrations
• pH at mineralization front
• A m o r p h o u s Ca, PO.,(ACP) preceding
hydroxyapatite formation (?)
• Vitamin D metabolites
1. Maintain adequate ambient Ca, PO,, levels
2. (?) Direct effect on osteoblasts a n d / o r mineralization front
• Parathyroid h o r m o n e
• Piezoelectric fields (exercise and stress)
• Inhibitors of mineralization
1. Pyrophosphates
) destroyed by
2. ATP (adenosine triphosphate)
V phosphatases
3. Foreign ions, such as a l u m i n u m
\ and ATPases
• Matrix vesicles
1. Facilitates mineral and enzyme concentration at the
mineralization front

Osteomalacia

rarely. Examples are seen primarily in rapidly growing
children w h o have subsisted on a calcium deficient diet.

minerals and enzymes, appearing at the initial site of
mineral deposition.

Hydrogen ion concentration appears to bean important
clinical factor at the mineralization front. Chronic systemic acidosis, as occurs in patients w h o have undergone ureterosigmoidostomy, can result in osteomalacia, even in the presence of normal serum levels of
calcium and phosphorus.

Bone matrix formation and its mineralization is a complex
process, and many possibilities exist for metabolic defects
which may lead to impaired mineralization. Further use
of electron spectroscopic imaging, as described by Arsenault and associates (pp. 220 ff.) should help define the
factors important for mineral deposition. These authors
demonstrated that an increased concentration of aluminum at the zone of calcification in the growth plate
retards normal mineralization in aluminum-treated rats.
Other studies have demonstrated the importance of
aluminum in inhibiting mineralization, both in the treatment resistant osteomalacia observed in hemodialysis
patients with renal osteodystrophy and in patients who
have been maintained on total parenteral nutrition. The
use of electron probes in association with histochemical
techniques offers promise in the study of the mineralization process. One day we may have a detailed map o f t h e
osteoid seam, where the concentrations of all important
factors needed for normal mineralization can be measured, and variations from normal can be detected.

Most theories of calcification suggest that crystalline
hydroxyapatite is preceded by an amorphous noncrystalline calcium phosphate complex, although recent studies
have questioned the validity of this concept.
The role of several vitamin D metabolites in bone mineralization is discussed extensively elsewhere in this Proceedings. The importance of these metabolites in maintaining adequate serum concentrations of calcium and
phosphorus is unquestioned. Whether they have an
additional direct effect on osteoblasts or on mineralization is hotly debated.
Parathyroid h o r m o n e appears to directly affect or
enhance the availability of minerals at the mineralization front. In some patients with renal osteodystrophy
decreased parathyroid function appearsto increase the
tendency toward a f o r m of osteomalacia that resists the
usual treatment.

Bone histomorphometry with the use of double tetracycline labeling techniques and undecalcified bone sections has come of age. An absence of osteomalacia, or at
the other extreme, florid osteomalacia, can readily be
identified by most established calcified tissue laboratories. However, there is less agreement on criteria for the
earliest histomorphometric signs of osteomalacia, especially when accompanied by secondary hyperparathyroidism. International agreement should be sought in establishing histodynamic criteria forall stages of osteomalacia
so that studies from different clinical research centers can
be compared more readily. Rao and others (pp. 224 ff.) in
Parfitt's laboratory at Henry Ford Hospital addressed this
problem. As kinetic criteria in making the diagnosis of
osteomalacia, these investigators use a mean osteoid
seam width of greater than 15.0/ym and a mineralization
lag time of greater than 100 days. They stressed that the
early effects of hypovitaminosis D are mainly those of
secondary hyperparathyroidism. As vitamin D deficient
osteopathy progresses, the mineralization defect becomes
more apparent, with a progressive accumulation of osteoid.

Exercise by initiating shearing forces on mineral crystals
induces electrical fields (piezoelectrical) that may influence bone formation. Fracture n o n - u n i o n is now being
successfully treated in some instances by application of
low-grade pulsed electrical currents. The importance of
such electrical fields in the process of normal matrix
formation and mineralization may be important but is
difficult to prove.
Just as important as the factors that enhance mineralization of bone matrix are the inhibitors of mineralization
that have been identified in bone. Both pyrophosphates
and ATP are known to impede different phases of mineral
formation and deposition, and removing these inhibitors
by endogenous pyrophosphatases (phosphatases) and
ATPases encourages mineralization. In hypophosphatasia, a condition with a deficiency of alkaline phosphatase
and an increase in the inhibitor phosphoethanolamine,
mineralization inhibitors may play an important role in
the development of rickets and osteomalacia.

Metabolic bone disease is a common problem in patients
with chronic liver disease. Patients with chronic biliary
tract obstruction are more likely to have osteomalacia
and patients with chronic diffuse hepatocellular disease
are more likely to have osteoporosis. I mportant etiologic
factors are defective vitamin D and 25 hydroxyvitamin D
absorption, impaired synthesis of 25 hydroxyvitamin D,
the deleterious effects of chronic alcoholism on the skel-

M u c h current investigation is centered on the role of
matrix vesicles in mineralization of cartilage and bone
matrix. These structures are detected by ultrastructural
examination at mineralizing sites in cartilage and bone.
They consist of membrane-bound concentrations of
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eton, hypoproteinemia, and other ill-defined nutritional
deficiencies. In view of this, the findings of Recker and
associates (pp. 227 ff.) in patients with primary biliary and
alcoholic cirrhosis were somewhat surprising. They found
no evidence of vitamin D deficiency or osteomalacia,
and bone histologic changes in both groups of patients
were indistinguishable from those patients with postmenopausal osteoporosis.
M u c h work still needs to be done to determine the
pathogenesis of the bone disease in patients with chronic
liver disorders. The type, degree, and duration of liver
disease needs to be correlated with defects in mineral
and vitamin D metabolism as well as with histomorphometric changes in the skeleton. The results of Recker and
associates are discouraging with respect to the possibility
of effective treatment in patients with metabolic bone
disease due to chronic liver failure, no matter what the
underlying etiology.
Many believe that sporadic hypophosphatemic osteomalacia in the adult is almost always related t o a n underlying tumor, usually mesenchymal. Such tumors may be
quite small and difficult to detect, but the effort to find
the m is w o r t h w h i l e , since successful removal often
improves or cures the underlying osteomalacia. Renal
phosphate wastage and hypophosphatemia appear to
cause osteomalacia in such patients.
Studies reported by Drezner and associates (pp. 242 ff.)
shed further light on this paraneoplastic syndrome of
tumor-induced osteomalacia. Their studies suggested
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further evidenceof a tumor-induced alteration of vitamin
D metabolism which may cause a urinary phosphate
leak. The tumor-producing agent that interferes with
renal 1-hydroxylation of 25 hydroxyvitamin D has so far
eluded identification.
Identifiable causes of osteomalacia continue to increase.
N o t s u r p r i s i n g l y , f o r e i g n ions deposited at the mineralization f r o n t can interfere with normal mineralization.
Ott and associates (pp. 237 ff.) presented evidence that
the etiology o f t h e metabolic bone disease observed in
patients receiving total parenteral nutrition (TPN) is
somewhat similar to the resistant f o r m of osteomalacia
observed in some patients w i t h renal osteodystrophy
w h o have been maintained on hemodialysis. In both
conditions, aluminum f r o m exogenoussources appears
to interfere w i t h normal mineral deposition. Removal
of the a l u m i n u m after the use of desferrioxamine
allows normal matrix mineralization to be restored. In
bone disease associated with total parenteral n u t r i t i o n ,
a l u m i n u m c o n t a m i n a t i o n o f t h e casein used in the TPN
solution may be the culprit. Steps should be taken to
insure that TPN solutions do not contain a l u m i n u m or
other potentially toxic trace elements that can impair
normal mineralization. If this approach is effective,
perhaps the painful disabling bone disease seen in
these patients will no longer be observed. However, it
should be remembered that not all workers have had a
similar experience w i t h regard to a l u m i n u m as an etiologic agent in TPN bone disease. This bone disorder
may have more than one cause.

